vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Huron Consulting Group Inc. (HURN). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $442.0M, roughly 2.2× Huron Consulting Group Inc.). Huron Consulting Group Inc. runs the higher net margin — 6.9% vs 0.7%, a 6.2% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 10.7%). Huron Consulting Group Inc. produced more free cash flow last quarter ($123.8M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 10.3%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Huron Consulting Group, commonly known as Huron, is a management consulting firm offering services to the healthcare, life sciences, commercial, and higher education industries.

ASTH vs HURN — Head-to-Head

Bigger by revenue
ASTH
ASTH
2.2× larger
ASTH
$950.5M
$442.0M
HURN
Growing faster (revenue YoY)
ASTH
ASTH
+32.2% gap
ASTH
42.9%
10.7%
HURN
Higher net margin
HURN
HURN
6.2% more per $
HURN
6.9%
0.7%
ASTH
More free cash flow
HURN
HURN
$129.8M more FCF
HURN
$123.8M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
10.3%
HURN

Income Statement — Q4 2025 vs Q4 2025

Metric
ASTH
ASTH
HURN
HURN
Revenue
$950.5M
$442.0M
Net Profit
$6.6M
$30.7M
Gross Margin
Operating Margin
1.9%
11.4%
Net Margin
0.7%
6.9%
Revenue YoY
42.9%
10.7%
Net Profit YoY
184.4%
-9.8%
EPS (diluted)
$0.12
$1.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
HURN
HURN
Q4 25
$950.5M
$442.0M
Q3 25
$956.0M
$441.3M
Q2 25
$654.8M
$411.8M
Q1 25
$620.4M
$404.1M
Q4 24
$665.2M
$399.3M
Q3 24
$478.7M
$378.1M
Q2 24
$486.3M
$381.0M
Q1 24
$404.4M
$363.4M
Net Profit
ASTH
ASTH
HURN
HURN
Q4 25
$6.6M
$30.7M
Q3 25
$373.0K
$30.4M
Q2 25
$9.4M
$19.4M
Q1 25
$6.7M
$24.5M
Q4 24
$-7.8M
$34.0M
Q3 24
$16.1M
$27.1M
Q2 24
$19.2M
$37.5M
Q1 24
$14.8M
$18.0M
Operating Margin
ASTH
ASTH
HURN
HURN
Q4 25
1.9%
11.4%
Q3 25
2.0%
11.3%
Q2 25
3.1%
11.1%
Q1 25
3.3%
8.1%
Q4 24
0.1%
11.8%
Q3 24
5.9%
11.2%
Q2 24
6.2%
15.6%
Q1 24
7.5%
5.5%
Net Margin
ASTH
ASTH
HURN
HURN
Q4 25
0.7%
6.9%
Q3 25
0.0%
6.9%
Q2 25
1.4%
4.7%
Q1 25
1.1%
6.1%
Q4 24
-1.2%
8.5%
Q3 24
3.4%
7.2%
Q2 24
3.9%
9.8%
Q1 24
3.7%
5.0%
EPS (diluted)
ASTH
ASTH
HURN
HURN
Q4 25
$0.12
$1.71
Q3 25
$0.01
$1.71
Q2 25
$0.19
$1.09
Q1 25
$0.14
$1.33
Q4 24
$-0.14
$1.82
Q3 24
$0.33
$1.47
Q2 24
$0.40
$2.03
Q1 24
$0.31
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
HURN
HURN
Cash + ST InvestmentsLiquidity on hand
$429.5M
$24.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$528.6M
Total Assets
$2.2B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
HURN
HURN
Q4 25
$429.5M
$24.5M
Q3 25
$463.4M
$23.9M
Q2 25
$342.1M
$61.0M
Q1 25
$260.9M
$23.4M
Q4 24
$290.8M
$21.9M
Q3 24
$350.3M
$18.5M
Q2 24
$327.7M
$17.6M
Q1 24
$337.3M
$18.6M
Stockholders' Equity
ASTH
ASTH
HURN
HURN
Q4 25
$779.3M
$528.6M
Q3 25
$775.5M
$499.8M
Q2 25
$765.5M
$475.0M
Q1 25
$745.4M
$494.3M
Q4 24
$712.7M
$561.3M
Q3 24
$704.6M
$522.8M
Q2 24
$678.9M
$500.6M
Q1 24
$653.5M
$495.6M
Total Assets
ASTH
ASTH
HURN
HURN
Q4 25
$2.2B
$1.5B
Q3 25
$2.2B
$1.5B
Q2 25
$1.4B
$1.5B
Q1 25
$1.3B
$1.4B
Q4 24
$1.4B
$1.3B
Q3 24
$1.3B
$1.3B
Q2 24
$1.3B
$1.3B
Q1 24
$1.2B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
HURN
HURN
Operating Cash FlowLast quarter
$-2.9M
$126.4M
Free Cash FlowOCF − Capex
$-6.0M
$123.8M
FCF MarginFCF / Revenue
-0.6%
28.0%
Capex IntensityCapex / Revenue
0.3%
0.6%
Cash ConversionOCF / Net Profit
-0.44×
4.12×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$183.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
HURN
HURN
Q4 25
$-2.9M
$126.4M
Q3 25
$10.0M
$93.8M
Q2 25
$90.9M
$80.0M
Q1 25
$16.6M
$-106.8M
Q4 24
$-10.9M
$139.6M
Q3 24
$34.0M
$85.2M
Q2 24
$23.2M
$107.2M
Q1 24
$6.0M
$-130.7M
Free Cash Flow
ASTH
ASTH
HURN
HURN
Q4 25
$-6.0M
$123.8M
Q3 25
$7.4M
$89.8M
Q2 25
$89.5M
$78.0M
Q1 25
$13.6M
$-108.7M
Q4 24
$-13.5M
$137.0M
Q3 24
$31.7M
$82.8M
Q2 24
$20.4M
$104.7M
Q1 24
$5.6M
$-131.9M
FCF Margin
ASTH
ASTH
HURN
HURN
Q4 25
-0.6%
28.0%
Q3 25
0.8%
20.3%
Q2 25
13.7%
18.9%
Q1 25
2.2%
-26.9%
Q4 24
-2.0%
34.3%
Q3 24
6.6%
21.9%
Q2 24
4.2%
27.5%
Q1 24
1.4%
-36.3%
Capex Intensity
ASTH
ASTH
HURN
HURN
Q4 25
0.3%
0.6%
Q3 25
0.3%
0.9%
Q2 25
0.2%
0.5%
Q1 25
0.5%
0.5%
Q4 24
0.4%
0.7%
Q3 24
0.5%
0.6%
Q2 24
0.6%
0.6%
Q1 24
0.1%
0.3%
Cash Conversion
ASTH
ASTH
HURN
HURN
Q4 25
-0.44×
4.12×
Q3 25
26.69×
3.08×
Q2 25
9.65×
4.12×
Q1 25
2.48×
-4.35×
Q4 24
4.11×
Q3 24
2.11×
3.14×
Q2 24
1.21×
2.86×
Q1 24
0.40×
-7.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

HURN
HURN

Consulting And Managed Services Capability$172.9M39%
Education$118.7M27%
Commercial$91.9M21%
Digital Capability$54.6M12%

Related Comparisons